Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02705404 · ClinicalTrials.gov registry record
A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 8
- Enrollment target
NCT02705404: Clinical Trial study, sponsored by Mayo Clinic.
NCT02705404 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02705404 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The investigators are doing this research to see if they can use small tissue samples or fluid to develop a test that will determine if the tissue samples are related or not related to each other. The test will use the patient's DNA, which is part of their unique genetic material that carries the instructions for the body's development and function. Cancer can result from changes in a person's genetic material that causes cells to divide in an uncontrolled way and, sometimes, to travel to other organs. Currently, researchers and doctors know some of the genetic changes that can cause cancer, but they do not know all of the genetic changes that can cause cancer.
Interventions
- GENETIC Multifocal Tissue Banking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-02-11 |
| Est. Completion | 2021-11-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02705404
The ClinicalTrials.gov registry entry for NCT02705404 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multifocal Tissue Banking is the first listed.
NCT02705404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02705404 about?
NCT02705404 is a clinical study titled "A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing". The investigators are doing this research to see if they can use small tissue samples or fluid to develop a test that will determine if the tissue samples are related or not related to each other. The test will use the patient's DNA, which is part of their unique genetic material that carries the in...
What is the current status of trial NCT02705404?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2016-02-11. Estimated completion is 2021-11-16.
What interventions are being tested in trial NCT02705404?
The interventions under investigation include: Multifocal Tissue Banking (GENETIC).
Who is sponsoring clinical trial NCT02705404?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.